|
Summary Toggle
Nov 14, 2022 at 4:30 PM EST
|
|
Q3 2022 Onconova Therapeutics, Inc. Corporate Update and Financial Results Conference Call
|
|
|
Summary Toggle
Sep 29, 2022
|
|
Ladenburg Thalmann 2022 Healthcare Conference
|
|
|
Summary Toggle
Sep 12, 2022 at 7:00 AM EDT
|
|
H.C. Wainwright 24th Annual Global Investment Conference
|
|
|
Summary Toggle
Aug 18, 2022 at 10:00 AM EDT
|
|
Reconvened Annual General Meeting
|
|
|
Summary Toggle
Aug 11, 2022 at 4:30 PM EDT
|
|
Q2 2022 Onconova Therapeutics, Inc. Corporate Update and Financial Results Conference Call
|
|
|
Summary Toggle
Jul 21, 2022 at 9:00 AM EDT
|
|
Annual General Meeting
The AGM is reconvened to August 18, 2022 10:00am ET.
|
|
|
Summary Toggle
May 11, 2022 at 4:30 PM EDT
|
|
Q1 2022 Onconova Therapeutics, Inc. Corporate Update and Financial Results Conference Call
|
|
|
Summary Toggle
Mar 17, 2022 at 4:30 PM EDT
|
|
Q4 2021 Onconova Therapeutics, Inc. Corporate Update and Financial Results Conference Call
|
|
|
Summary Toggle
Feb 10, 2022
|
|
Guggenheim Oncology Conference (Feb 9-11, 2022)
|
|
|
Summary Toggle
Jan 10 - Jan 14, 2022
|
|
H.C. Wainwright BIOCONNECT Virtual Conference
|
|
|
Summary Toggle
Nov 25 - Nov 27, 2021
|
|
Austrian Society of Dermatology and Venerology Annual Conference (Nov 25-27, 2021)
|
|
|
Summary Toggle
Nov 22 - Dec 2, 2021
|
|
Piper Sandler 33rd Annual Virtual Healthcare Conference
|
|
|
Summary Toggle
Nov 11, 2021 at 4:30 PM EST
|
|
Q3 2021 Onconova Therapeutics, Inc. Corporate Update and Financial Results Conference Call
|
|
|
Summary Toggle
Sep 22, 2021 at 4:30 PM EDT
|
|
Webinar Featuring Expert Overview from Key Opinion Leaders
|
|
|
Summary Toggle
Sep 22, 2021
|
|
3rd Annual RAS Targeted Drug Development Summit 11:30 a.m. ET
Phase 1/2 Trial of Rigosertib & Nivolumab in KRAS-Mutated NSCLC in 2nd+ Line presented by Rajwanth Veluswamy, MD MSCR, Assistant Professor of Medicine, Icahn School of Medicine at Mount Sinai, NYC
|
|
|
Summary Toggle
Sep 13 - Sep 15, 2021
|
|
H.C. Wainwright 23rd Annual Global Investment Conference
|
|
|
Summary Toggle
Aug 12, 2021 at 4:30 PM EDT
|
|
Q2 2021 Onconova Therapeutics, Inc. Corporate Update and Financial Results Conference Call
|
|
|
Summary Toggle
Jul 30, 2021 at 11:00 AM EDT
|
|
2021 Annual Meeting of Stockholders (Virtual)
|
|
|
Summary Toggle
Jun 10 - Jun 18, 2021
|
|
Presentation at 2021 BIO Digital
|
|
|
Summary Toggle
May 17, 2021 at 4:30 PM EDT
|
|
Q1 2021 Onconova Therapeutics, Inc. Corporate Update and Financial Results Conference Call
|
|
